← Leaderboards
Paul Yazaki
City Of Hope National Medical Center
$5,458,492
Attributed
$7,534,898
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,534,898 · 6
By mechanism
P01$4,544,693 · 4
R01$1,994,976 · 1
R44$995,229 · 1
Top collaborators
- John E. Shively3 shared
- Jeffrey Y Wong3 shared
- David Morris Colcher2 shared
- Andrew A. Raubitschek2 shared
- David T Ho1 shared
- Bradley T Wyman1 shared
Most similar at City Of Hope National Medical Center
Same institution · by research overlap
- Andrew A. Raubitschek$10,642,515
- Michael C Jensen$5,983,472
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesLengthProductionRecombinantsBaseSolid NeoplasmRadiationGenerationsMonoclonal AntibodiesImmunotherapyPositron-Emission TomographyTumorPrincipal InvestigatorRadioimmunotherapyReagentImagePropertyBiotinIl2 GeneCellsBioreactorsClinical TrialsSafetyEnvironment
Grant awards (19)
Targeted radiation and immunocytokine therapy for CEA positive malignancies$676,263
R01 · FY2025 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies$642,450
R01 · FY2024 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies$676,263
R01 · FY2023 · CA
Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea$923,853
R44 · FY2012 · CA
CLINICAL PRODUCTION$250,893
P01 · FY2012 · CA · contact PI
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY$374,826
P01 · FY2011 · CA · contact PI
Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea$71,376
R44 · FY2011 · CA
CLINICAL PRODUCTION$1
P01 · FY2011 · CA · contact PI
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY$655,780
P01 · FY2010 · CA · contact PI
CLINICAL PRODUCTION$316,618
P01 · FY2010 · CA · contact PI
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY$642,945
P01 · FY2009 · CA · contact PI
CLINICAL PRODUCTION$310,412
P01 · FY2009 · CA · contact PI
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY$623,885
P01 · FY2008 · CA · contact PI
CLINICAL PRODUCTION$301,229
P01 · FY2008 · CA · contact PI
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY$614,782
P01 · FY2007 · CA · contact PI
CLINICAL PRODUCTION$296,825
P01 · FY2007 · CA · contact PI
CORE--CLINICAL PRODUCTION$0
P01 · FY2002 · CA
CORE--EXPRESSION AND PRODUCTION$0
P01 · FY2001 · CA
CORE--EXPRESSION AND PRODUCTION$156,497
P01 · FY2000 · CA